DB00065 : a novel treatment for sight-threatening thyroid associated ophthalmopathy . We describe a patient with sight threatening thyroid associated ophthalmopathy ( DB01361 ) who was successfully treated with infliximab , an anti-tumour necrosis factor ( P01375 ) -a antibody .